Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-06

Clinical Trial Update: Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ranolazine and dronedarone, alone and in combination, in patients with paroxysmal atrial fibrillation; the trial is completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronedarone (dronedarone)
  • Ranolazine (ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2020-11-06